News Daily News EuroPCR 2025 Underexpanded Acurate neo2 Valves Tied to Worse Outcomes: ACURATE IDE Michael O'Riordan May 28, 2025
News Conference News ACC 2025 Evolut Low Risk Trial: TAVI Holds Up to Surgery at 5 Years L.A. McKeown March 30, 2025
News Conference News ACC 2025 More ALIGN-AR Data Bolster Potential for a Dedicated AR Device Yael L. Maxwell March 30, 2025
News Conference News TCT 2024 ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients Todd Neale October 30, 2024
News Conference News CRT 2023 New Durability Definitions Still Give Self-Expanding TAVI an Edge vs SAVR Yael L. Maxwell March 03, 2023
News Conference News TCT 2022 Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year L.A. McKeown September 23, 2022
News Conference News TCT 2022 Surgical TAVI Explants Are Risky and Rising: STS Data Carry a Warning Shelley Wood September 19, 2022
News Daily News TAVR Yields Similar Success in Failed TAVR or Surgical Valves Caitlin E. Cox January 07, 2021
News Daily News SAVR After Failed TAVR: Rare and Risky, Registry Study Finds Yael L. Maxwell June 10, 2020
News Conference News CRT 2020 Positive Early Data for TAVR in Low-Risk Patients With Bicuspid Valves Michael O'Riordan February 27, 2020
News Daily News New TAVR NCD a ‘Missed Opportunity’ to Align SAVR, TAVR Quality Shelley Wood June 27, 2019
News Conference News TVT 2019 Transcarotid Bests Aortic/Apical for Alternative TAVR Access: TVT Registry Shelley Wood June 17, 2019
News Daily News FDA Approves Lotus Edge, Ushering Third Device Into US Market Shelley Wood April 24, 2019
News Daily News Lotus Maintains Good Safety, Efficacy at 2 Years, Though Questions Persist Over Permanent Pacing Yael L. Maxwell March 01, 2019